AACR and MPM Oncology Charitable Foundation Announce Three Grants to Support Transformative Cancer Research
PHILADELPHIA, PA and CAMBRIDGE, MA – January 19, 2021 — Three grants for research that could transform cancer therapies...
Search/Filter
Loading...
The Lustgarten Foundation and the AACR Honor Two American Icons Lost to Pancreatic Cancer with New Career Development Awards for Researchers
The Lustgarten Foundation and the American Association for Cancer Research (AACR) have established two new career development awards for...
Incidence of Esophageal Adenocarcinoma is Increasing in Younger Adults
Analysis shows that patients under age 50 are more likely to be diagnosed at advanced stages PHILADELPHIA – Esophageal...
Circulating Tumor Cell Dynamics May Predict Treatment Response and Prognosis in Patients with Metastatic Breast Cancer
SAN ANTONIO – Early circulating tumor cell dynamics were associated with overall survival in patients with metastatic breast cancer,...
Under-recognition of Symptoms May Be Common in Patients With Breast Cancer Receiving Radiotherapy
Symptom under-recognition may be more common among younger patients and Black patients SAN ANTONIO – Among patients with breast...
Women Who Undergo Mastectomy and Reconstructive Surgery May Be at Risk of Becoming Persistent Drug Users
SAN ANTONIO – Women who receive mastectomy and reconstructive surgery as part of breast cancer treatment may face the...
Postmenopausal Women With Early-stage Breast Cancer and Low Recurrence Score Could Skip Adjuvant Chemotherapy
Adjuvant chemotherapy may yield improved survival outcomes for premenopausal counterparts SAN ANTONIO – After a median follow-up of 5.1...
Omitting Radiation Therapy After Breast-Conserving Surgery May Not Impact 10-year Survival Rates for Older Patients With HR-positive Breast Cancer
SAN ANTONIO – Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery...
Breast Cancer Survivors Are Less Likely to Get Pregnant, but Often Have Healthy Babies and Good Long-term Health
SAN ANTONIO – A large meta-analysis of breast cancer survivors of childbearing age indicated that they are less likely...
Updated monarchE Trial Data Shows Abemaciclib Continues to Benefit Patients With High-risk, HR-positive, HER2-negative, Early-stage Breast Cancer
SAN ANTONIO – Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK)...